Similarly, dysregulation of the adaptative immunity in AD patients, particularly in the response of CD4+ T-helper cells, leads to the overexpression of IL-17 and IL-22 cytokines, both of which have been associated with acute and chronic AD lesions [45,46]. This evidence concerns the gene IL17A and Alzheimer disease.